Status:
COMPLETED
Children and Parents With ADHD and Related Disorders
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
General Population
TDAH
Eligibility:
All Genders
5-18 years
Brief Summary
Almost all rating scales for Attention-Deficit/Hyperactivity Disorder (ADHD) are not validated in France. This clearly hampers the development of the diagnosis and the monitoring of patients but also ...
Eligibility Criteria
Inclusion
- Child known for the teacher for at least three months so that his evaluation Reflect most faithfully possible the usual behavior of the child,
- Child having the Frenchman for mother tongue to avoid the consequences on him Behavior of a linguistic obstacle,
- Authorization to use the data signed by at least one of the parents of the child and by the very child when he is old at least of six years.
- Parents speaking and reading the Frenchman.
Exclusion
- Child known to follow a specific treatment of a disorder(confusion)attentional with / without Hyperactivity-impulsiveness (eg. Ritaline Ò, Ritaline Ò LP, Arranged Ò LP, Strattera Ò) Whatever is its duration. Indeed, a selection on this criterion would introduce a way Major which(who) would return the less reliable results(profits) of the study.
- Child presenting a known neurological or psychiatric disorder, or a deficit Intellectual because the attentional disorders(confusions), the psychomotor excitement and The impulsiveness can be symptoms inherent to the other pathologies Neurological and\\or psychiatric.
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
2600 Patients enrolled
Trial Details
Trial ID
NCT01260792
Start Date
February 1 2010
End Date
December 1 2011
Last Update
March 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000